Submissions from 2025
Editorial Commentary, David Taub
Locally advanced pancreatic cancer treated with surgical resection after chemotherapy, Samuel Kareff
Postmastectomy Radiation Therapy: An ASTRO-ASCO-SSO Clinical Practice Guideline, Youssef Zeidan
Postmastectomy Radiation Therapy: An ASTRO/ASCO/SSO Clinical Practice Guideline, Youssef Zeidan
Postmastectomy Radiation Therapy: An ASTRO/ASCO/SSO Clinical Practice Guideline, Youssef Zeidan
What guides regional nodal irradiation in node positive breast cancer following upfront sentinel lymph node biopsy?, Youssef Zeidan
Submissions from 2024
Quantifying the Dosimetric Impact of Proton Range Uncertainties on RBE-Weighted Dose Distributions in Intensity-Modulated Proton Therapy for Bilateral Head and Neck Cancer, Suresh Rana, Noufal Manthala Padannayil, Hina Saeed, and Michael Kasper
ACR-ARS Practice Parameter for Communication: Radiation Oncology, Hina Saeed
Editorial Commentary, David Taub
Elevated expression of ANTXR1 gene in tumors is a poor prognostic biomarker for patients with bladder cancer, Samuel Kareff
Exploring the dosimetric impact of systematic and random setup uncertainties in robust optimization of head and neck IMPT plans, Suresh Rana, Noufal Manthala Padannayil, Youssef Zeidan, Shyam Pokharel, Samuel Richter, Michael Kasper, and Hina Saeed
Submissions from 2023
Targeting the IL4 receptor with MDNA55 in patients with recurrent glioblastoma: Results of a phase IIb trial, Sajeel Chowdhary
Alliance A071401: Phase II Trial of Focal Adhesion Kinase Inhibition in Meningiomas With Somatic NF2 Mutations, Sajeel Chowdhary
A general framework to develop a radiomic fingerprint for progression-free survival in cervical cancer, Hina Saeed
A novel Monte Carlo (MC) dose model for small MLC fields of the cyberknife(®) M6(TM) radiosurgery system using the EGSnrc, Michael Kasper
Editorial Comment, David Taub
Editorial Comment, David Taub
Judaism, Patricia Jacobs
One size does not fit all: PMRT in ypN0 HER-2 positive breast cancer, Youssef Zeidan
The role of artificial intelligence in hastening time to recruitment in clinical trials, Hina Saeed
WeWhoCurie: An Initiative to Advocate for Those Underrepresented in Radiation Oncology, Hina Saeed